Raimund I. Herzog MD, MHSAssociate Professor of Medicine, Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut
Dr. Raimund Herzog is an Assistant Professor in Endocrinology at Yale School of Medicine. He received his M.D. from University of Ulm, Germany before moving to the US, where he pursued his training in Internal Medicine at Yale School of Medicine. He earned his M.H.S. in the YCCI Junior Faculty Scholars program while further specializing in Endocrinology at Yale. In addition to caring for patients at the Yale Diabetes Center and teaching medical students Dr. Herzog maintains an active translational research program. A physician scientist with a strong interest in neuroscience and diabetes, Dr. Herzog’s laboratory is focused on characterizing and preventing its central nervous complications. He uses state-of-the-art technologies like in vivo NMR spectroscopy and phospho-proteomics to define the impact of diabetes and intensive insulin treatment on brain metabolism and cognition. His work extends from cell culture and animal models all the way to translation of findings to human subjects. It has produced novel insights into the molecular mechanisms underlying brain energy substrate metabolism thereby laying the basis for the development of targeted therapies that will protect the brain from diabetes complications and injury. In a related area Dr. Herzog’s workgroup has engaged in several collaborative projects that apply his understanding of metabolism towards more comprehensive and unbiased metabolomic analysis of peripheral plasma metabolites in an obese and diabetic adolescent cohort. Furthermore he is exploring the role of circulating small molecules and lipids in the context of aging-related cognitive decline in a cohort of elderly subjects. As part of his studies he has established a close working relationship with the Magnetic Resonance Research Center, Keck Mass Spectrometry Center and the Biostatistics Resource at Yale. His studies are funded by several NIH and private foundation awards and have resulted in high impact publications in journals like The Journal of Clinical Investigation, Diabetes and Endocrinology.
Recent Contributions to PracticeUpdate:
- Impaired Responses to Hypoglycemia After Oral Glucose in Patients With Cystic Fibrosis
- Loss of Incretin Effect Contributes to Postprandial Hyperglycemia in Cystic Fibrosis–Related Diabetes
- Exenatide Corrects Postprandial Hyperglycemia in Youth With Cystic Fibrosis and Impaired Glucose Tolerance
- Gastric Bypass Surgery Resets Glucose Homeostasis
- All-Cause Mortality and Cardiovascular Disease Associated With Prior History of Hypoglycemia in Type 1 Diabetes